Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion type Assertion NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_head.
- NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion description "[Our study suggests that PHA- 767491 could enhance the efficacy of 5-FU by inhibiting Chk1 phosphorylation and down-regulating Mcl1 expression through inhibition of Cdc7 and Cdk9, thus combinational administration of PHA-767491 with 5-FU could be potentially beneficial to patients with advanced and resistant HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_provenance.
- NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion evidence source_evidence_literature NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_provenance.
- NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion SIO_000772 25643258 NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_provenance.
- NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion wasDerivedFrom befree-2016 NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_provenance.
- NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion wasGeneratedBy ECO_0000203 NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_provenance.